GSK plc (LSE/NYSE:GSK), a $70.68 billion pharmaceutical giant with an impressive 71.81% gross profit margin, has announced that its novel 5-in-1 meningococcal vaccine, Penmenvy, received a ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GSK sued Pfizer in 2023, arguing that the New York-based company's vaccine infringed GSK patents related to antigen technology. GSK said in the lawsuit that Pfizer began working on its RSV program ...

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws ...

GSK plc (LSE/NYSE:LON:GSK), a $70.68 billion pharmaceutical giant with an impressive 71.81% gross profit margin, has announced that its novel 5-in-1 meningococcal vaccine, Penmenvy, received a ...

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates ...